Inventiva S.A. reports nine-months results
Source: SeekingAlpha
2025-11-24 07:48:23 ET
More on Inventiva S.A
- Inventiva S.A. (IVA) Analyst/Investor Day - Slideshow
- Inventiva S.A. (IVA) Analyst/Investor Day Transcript
- Inventiva announces $125M U.S. public offering of ADSs
- MASH drug developers rise as FDA accepts lenient trial requirement
- Seeking Alpha’s Quant Rating on Inventiva S.A
Read the full article on Seeking Alpha
For further details see:
Inventiva S.A. reports nine-months results
Inventiva
NASDAQ: IVEVF
IVEVF Trading
-1.44% G/L:
$4.12 Last:
1,000 Volume:
$4.12 Open:
IVEVF Latest News
February 04, 2026 04:00:00 pm
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
December 17, 2025 04:00:00 pm
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
IVEVF Stock Data
$568,234,603
18,487,278
N/A
14
N/A
Biotechnology & Life Sciences
Healthcare
FR
Daix
